Skip to main content
. 2020 Dec 9;39:278. doi: 10.1186/s13046-020-01792-8

Fig. 1.

Fig. 1

Kaplan-Meier estimates of survival rates of R/R AML (acute myeloid leukemia) patients following combination therapy of chidamide and anthracycline-based regimen. a OS. b Progression-free survival